American Chemical Society - 229th National Meeting: general oral and poster sessions.
Mackonochie
Marion
M
Thomson Scientific, Middlesex House, London, UK. Marion.Mackonochie@thomson.com
Chan
Danny
D
D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors; D002626:Chemistry, Pharmaceutical / Q000379:methods* / Q000639:trends; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005085:Exhibitions as Topic; D006597:Fructose-Bisphosphatase / Q000037:antagonists & inhibitors; D000882:Haplorhini; D006801:Humans; D033181:Information Dissemination / Q000379:methods; D008288:Malaria / Q000188:drug therapy; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D015800:Protozoan Proteins; D012958:Societies, Scientific; D014376:Tuberculosis / Q000188:drug therapy / Q000382:microbiology; D014481:United States
D004791:Enzyme Inhibitors; D015800:Protozoan Proteins; D006597:Fructose-Bisphosphatase; D016282:Aspartic Acid Endopeptidases; C100637:plasmepsin II